$1.04
1.89% today
Nasdaq, Feb 05, 04:19 pm CET
ISIN
US09073N2018
Symbol
BSGM

BioSig Technologies, Inc. Stock price

$1.06
-0.39 26.90% 1M
+0.72 210.85% 6M
-0.43 28.86% YTD
-0.03 2.60% 1Y
-15.34 93.54% 3Y
-47.94 97.84% 5Y
-47.69 97.83% 10Y
Nasdaq, Closing price Tue, Feb 04 2025
+0.02 1.92%
ISIN
US09073N2018
Symbol
BSGM
Sector

Key metrics

Market capitalization $18.27m
Enterprise Value $17.93m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 448.25
P/S ratio (TTM) P/S ratio 456.75
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth -72.34%
Revenue (TTM) Revenue $40.00k
EBIT (operating result TTM) EBIT $-17.59m
Free Cash Flow (TTM) Free Cash Flow $-7.23m
Cash position $620.00k
EPS (TTM) EPS $-1.45
Short interest 1.27%
Show more

Is BioSig Technologies, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,821 stocks worldwide.

BioSig Technologies, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast BioSig Technologies, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast BioSig Technologies, Inc.:

Buy
100%

Financial data from BioSig Technologies, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
0.04 0.04
71% 71%
100%
- Direct Costs 0.25 0.25
62% 62%
625%
-0.21 -0.21
59% 59%
-525%
- Selling and Administrative Expenses 15 15
34% 34%
38,050%
- Research and Development Expense 1.91 1.91
62% 62%
4,775%
-17 -17
40% 40%
-43,350%
- Depreciation and Amortization 0.25 0.25
60% 60%
625%
EBIT (Operating Income) EBIT -18 -18
40% 40%
-43,983%
Net Profit -15 -15
49% 49%
-38,200%

In millions USD.

Don't miss a Thing! We will send you all news about BioSig Technologies, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

BioSig Technologies, Inc. Stock News

Neutral
GlobeNewsWire
3 months ago
Los Angeles, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “Company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization,  today announced that it has received notice from the Nasdaq Listing Qualifications staff ("Nasdaq") informing the Company that it has regained compliance with the ...
Neutral
GlobeNewsWire
4 months ago
Los Angeles, CA, Oct. 22, 2024 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM) (“BioSig” or the “Company"), a medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization, today announced its successful appeal to the NASDAQ Panel, and as a result the Company's common stock will resume trading on the NASDAQ Capital Market Exchange a...

Company Profile

BioSig Technologies, Inc. is a medical technology company. It engages in the development of a proprietary biomedical signal processing platform designed to improve the electrophysiology (EP) marketplace. The firm is preparing to commercialize its PURE EP System. BioSig Technologies was founded by Kenneth L. Londoner on February 24, 2009 and is headquartered in Westport. CT.

Head office United States
CEO Anthony Amato
Employees 4
Founded 2009
Website www.biosig.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today